[ad_1] Chinese researcher claims to have created the first genetically modified babies using CRISPR / Cas9 tools that have become a common feature in laboratories around the world. And the news has …
Read More »
[ad_1] Novartis management has achieved the positive results they have been expecting from Entresto's PIONEER-HF study to confirm accelerated sales of heart medicines. Initially slow, prevented by reluctant doctors from adopting a …
Read More »
[ad_1] Faced with the slow adoption of Trulance, his constipation medication, Synergy Pharmaceuticals $ SGYP has practically thrown in the towel, claiming that he was not planning to receive bids of purchase …
Read More »
[ad_1] Amarin $ AMRN has claimed the next big hit in the cardio space, announcing an obvious statistical victory over the main criterion for its 7-year clinical research aimed at proving that …
Read More »